Tvardi

Public

Sugar Land, TexasHealthcarehttps://www.tvarditherapeutics.com

Tvardi is now publicly traded

The data on this page reflects Tvardi's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Equity

Dec 18, 2024

Total Funding Raised

$111.3M

Company Overview

Tvardi Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors of STAT3 to provide innovative treatments for breast and lung cancer, as well as addressing various inflammatory and fibrotic diseases.

Sector

Healthcare

AI Layer

Non-AI

Keywords

oral STAT3 inhibitorfirst-in-class STAT3 inhibitoridiopathic pulmonary fibrosis (IPF) therapyhepatocellular carcinoma (HCC) therapyfibrosis-driven disease therapytherapy for treatment-resistant cancertherapy targeting transcription factorsnext-generation oral STAT3 inhibitorsmall molecule drug discoveryclinical-stage biopharmaceutical

Tvardi Comparables

Compare Tvardi with similar companies based on industry and business-model similarity.

Tvardi comparables — related companies by embedding similarity
Company	Similarity	Market Cap
ImmunoMet Therapeutics	72%
Incyte Corporation	61%
FibroNox	58%

View all Comparables

Tvardi Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	Dec 18, 2024
Series B	Jun 23, 2021
Series A	Sep 20, 2018

View all Funding Rounds

Tvardi Investors

Notable investors and investment history

Tvardi investors
Investor	Rounds
ArrowMark Partners	Series B
National Foundation for Cancer Research	Series B
Palkon Capital Management	Series B
Slate Path Capital	Series B

View all Investors

Tvardi Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tvardi Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSugar Land, Texas

Employee Range20

Year Founded2017

Last FundingDec 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?